ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia
Alexandria TM Lee,1 Saihong Ignatius Ou1,2 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence: Saihong Ignatius Ou, University of California Irvine School of Medicine, Department of Med...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Dove Medical Press
2023-07-01
|
| Серія: | Lung Cancer: Targets and Therapy |
| Предмети: | |
| Онлайн доступ: | https://www.dovepress.com/alesia-5-year-update-alectinib-at-600-mg-twice-daily-gives-lorlatinib--peer-reviewed-fulltext-article-LCTT |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|